TY - JOUR
T1 - Atg7 Knockdown Reduces Chemerin Secretion in Murine Adipocytes
AU - Heinitz, Sascha
AU - Gebhardt, Claudia
AU - Piaggi, Paolo
AU - Krüger, Jacqueline
AU - Heyne, Henrike
AU - Weiner, Juliane
AU - Heiker, John T.
AU - Stumvoll, Michael
AU - Blüher, Matthias
AU - Baier, Leslie
AU - Rudich, Assaf
AU - Kovacs, Peter
AU - Tönjes, Anke
N1 - Publisher Copyright:
Copyright © 2019 Endocrine Society.
PY - 2019/11/1
Y1 - 2019/11/1
N2 - Context: In individuals with obesity, adipocyte endocrine function is affected by altered autophagy. Genetic variants in autophagy-related gene 7 (ATG7) correlated with serum chemerin (RARRES2) concentrations. Objectives: To investigate a functional interplay between chemerin and ATG7, how it may relate to autophagy-mediated adipocyte dysfunction in obesity, and the relevance of genetic ATG7 variants in chemerin physiology. Design: Adipose ATG7 mRNA expression and adiposity measures were available in two human study cohorts. The effect of a high-calorie diet on adipose Rarres2 and Atg7 expression was investigated in mice. In 3T3-L1 adipocytes, the effect of Atg7 knockdown on chemerin expression and secretion was studied. The influence of single nucleotide polymorphisms on ATG7 transcription and chemerin physiology was investigated using a luciferase assay. Setting: Mouse model, clinical trials, in vitro studies. Participants: Native American (n = 83) and white (n = 100) cohorts. Main outcome measure: Adipocyte chemerin expression and secretion. Results: In mice fed a high-calorie diet, adipose Atg7 mRNA expression did not parallel an increase in Rarres2 mRNA expression. ATG7 mRNA expression in human subcutaneous adipose tissue correlated with body mass index, fat mass (r > 0.27; P < 0.01), and adipocyte cell size (r > 0.24; P < 0.02). Atg7 knockdown in 3T3-L1 adipocytes decreased chemerin secretion by 22% (P < 0.04). Rs2606729 in ATG7 was predicted to alter ATG7 transcription and induced higher luciferase activity in vitro (P < 0.0001). Conclusions: Human adipose ATG7 mRNA expression relates to measures of adiposity. Atg7 knockdown reduces chemerin secretion from adipocytes in vitro, supportive of a functional interplay between ATG7 and chemerin in autophagy-mediated adipocyte dysfunction.
AB - Context: In individuals with obesity, adipocyte endocrine function is affected by altered autophagy. Genetic variants in autophagy-related gene 7 (ATG7) correlated with serum chemerin (RARRES2) concentrations. Objectives: To investigate a functional interplay between chemerin and ATG7, how it may relate to autophagy-mediated adipocyte dysfunction in obesity, and the relevance of genetic ATG7 variants in chemerin physiology. Design: Adipose ATG7 mRNA expression and adiposity measures were available in two human study cohorts. The effect of a high-calorie diet on adipose Rarres2 and Atg7 expression was investigated in mice. In 3T3-L1 adipocytes, the effect of Atg7 knockdown on chemerin expression and secretion was studied. The influence of single nucleotide polymorphisms on ATG7 transcription and chemerin physiology was investigated using a luciferase assay. Setting: Mouse model, clinical trials, in vitro studies. Participants: Native American (n = 83) and white (n = 100) cohorts. Main outcome measure: Adipocyte chemerin expression and secretion. Results: In mice fed a high-calorie diet, adipose Atg7 mRNA expression did not parallel an increase in Rarres2 mRNA expression. ATG7 mRNA expression in human subcutaneous adipose tissue correlated with body mass index, fat mass (r > 0.27; P < 0.01), and adipocyte cell size (r > 0.24; P < 0.02). Atg7 knockdown in 3T3-L1 adipocytes decreased chemerin secretion by 22% (P < 0.04). Rs2606729 in ATG7 was predicted to alter ATG7 transcription and induced higher luciferase activity in vitro (P < 0.0001). Conclusions: Human adipose ATG7 mRNA expression relates to measures of adiposity. Atg7 knockdown reduces chemerin secretion from adipocytes in vitro, supportive of a functional interplay between ATG7 and chemerin in autophagy-mediated adipocyte dysfunction.
UR - http://www.scopus.com/inward/record.url?scp=85073182908&partnerID=8YFLogxK
U2 - 10.1210/jc.2018-01980
DO - 10.1210/jc.2018-01980
M3 - Article
AN - SCOPUS:85073182908
SN - 0021-972X
VL - 104
SP - 5715
EP - 5728
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 11
ER -